Business
Transgene to Participate in Upcoming Investor Meetings
Strasbourg, France, April 7, 2026, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced that its management team will meet institutional investors during the upcoming editions of: Investor Access Event (by Allinvest Securities), on April 9, 2026, in Paris (France);Life Sciences Conference (by Van Lanschot Kempen), on April 16, 2026, in Amsterdam (Netherlands). Next financial communica
About this update from Transgene Sa
[{"type":"image","alt":"Transgene S.A.","displaySize":"","headline":null,"caption":"Transgene S.A.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":61,"url":"https://media.zenfs.com/en/globenewswire.com/119332f9b32809dd33752947f57270b6"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/jqPPFIE0hf_R.ovtyG3lPQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTg1/https://media.zenfs.com/en/globenewswire.com/119332f9b32809dd33752947f57270b6","width":300,"height":61}},"lazy":false},{"type":"text","content":"Strasbourg, France, April 7, 2026, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced that its management team will meet institutional investors during the upcoming editions of:","length":292,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Investor Access Event (by Allinvest Securities), on April 9, 2026, in Paris (France);","length":85,"tagName":"p"}]},{"val":[{"type":"text","content":"Life Sciences Conference (by Van Lanschot Kempen), on April 16, 2026, in Amsterdam (Netherlands).","length":97,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":182,"olType":false},{"type":"text","content":"Next financial communications:","length":30,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"April 29, 2026: First Quarter 2026 Financial Results","length":52,"tagName":"p"}]},{"val":[{"type":"text","content":"May 22, 2026: Annual Shareholders’ Meeting","length":42,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":94,"olType":false},{"type":"text","content":"***","length":3,"tagName":"p"},{"type":"text","content":"Contacts ","length":8,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"style":"width:379.2px;vertical-align:middle;text-align:left;padding-left:15.0px;text-align:justify;vertical-align:middle;vertical-align:top;","val":[{"type":"text","content":"Transgene:","length":10,"tagName":"p","attribs":{}}]},{"style":"width:225.6px;text-align:justify;vertical-align:middle;vertical-align:top;","val":[{"type":"text","content":" ","length":6,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"width:379.2px;vertical-align:middle;text-align:left;padding-left:15.0px;text-align:justify;vertical-align:middle;vertical-align:top;","val":[{"type":"text"...